Subsequently, in vivo studies on subcutaneous tumor xenografts in nude mice demonstrated that METTL1 knockdown could inhibit tumor growth, while overexpression of BRCA1 could reverse the inhibited tumor growth caused by METTL1 downregulation (Fig. 2J and K, all p < 0.0001). The gene discussed is METTL1; the disease is neoplasm.